Michael S. Leslie

Array ( [id] => 2876001 [patent_doc_number] => 05158955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-27 [patent_title] => 'Cosmetic composition comprising an ester of pyroglutamic acid' [patent_app_type] => 1 [patent_app_number] => 7/807778 [patent_app_country] => US [patent_app_date] => 1991-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6049 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/158/05158955.pdf [firstpage_image] =>[orig_patent_app_number] => 807778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2794486 [patent_doc_number] => 05143925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-01 [patent_title] => 'Alteration of rate and character of hair growth' [patent_app_type] => 1 [patent_app_number] => 7/794321 [patent_app_country] => US [patent_app_date] => 1991-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1396 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/143/05143925.pdf [firstpage_image] =>[orig_patent_app_number] => 794321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2773394 [patent_doc_number] => 05132293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-21 [patent_title] => 'Enzymic alteration of hair growth' [patent_app_type] => 1 [patent_app_number] => 7/784650 [patent_app_country] => US [patent_app_date] => 1991-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1968 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/132/05132293.pdf [firstpage_image] =>[orig_patent_app_number] => 784650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2803462 [patent_doc_number] => 05145851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-08 [patent_title] => 'Method for treating urinary obstruction' [patent_app_type] => 1 [patent_app_number] => 7/780405 [patent_app_country] => US [patent_app_date] => 1991-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2413 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/145/05145851.pdf [firstpage_image] =>[orig_patent_app_number] => 780405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2791270 [patent_doc_number] => 05102913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-07 [patent_title] => 'Treatment for cocaine use employing valproic acid' [patent_app_type] => 1 [patent_app_number] => 7/724105 [patent_app_country] => US [patent_app_date] => 1991-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3249 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/102/05102913.pdf [firstpage_image] =>[orig_patent_app_number] => 724105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2830451 [patent_doc_number] => 05128373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-07 [patent_title] => 'Packages containing injectable formulations of the sodium salt of naproxen' [patent_app_type] => 1 [patent_app_number] => 7/679113 [patent_app_country] => US [patent_app_date] => 1991-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 2529 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/128/05128373.pdf [firstpage_image] =>[orig_patent_app_number] => 679113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2805580 [patent_doc_number] => 05157025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-20 [patent_title] => 'Method for lowering serum cholesterol employing a phosphorus containing ACE inhibitor alone or in combination with a cholesterol lowering drug' [patent_app_type] => 1 [patent_app_number] => 7/677921 [patent_app_country] => US [patent_app_date] => 1991-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10199 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/157/05157025.pdf [firstpage_image] =>[orig_patent_app_number] => 677921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2803611 [patent_doc_number] => 05145859 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-08 [patent_title] => 'Methods of treating interstitial cystitis and urethral syndrome' [patent_app_type] => 1 [patent_app_number] => 7/672393 [patent_app_country] => US [patent_app_date] => 1991-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5949 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/145/05145859.pdf [firstpage_image] =>[orig_patent_app_number] => 672393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2868301 [patent_doc_number] => 05162375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Treatment of neuronal degeneration with 5HT1.sub.A agonists' [patent_app_type] => 1 [patent_app_number] => 7/662784 [patent_app_country] => US [patent_app_date] => 1991-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1627 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162375.pdf [firstpage_image] =>[orig_patent_app_number] => 662784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2823947 [patent_doc_number] => 05095027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-10 [patent_title] => 'Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid' [patent_app_type] => 1 [patent_app_number] => 7/662557 [patent_app_country] => US [patent_app_date] => 1991-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6994 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/095/05095027.pdf [firstpage_image] =>[orig_patent_app_number] => 662557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2867674 [patent_doc_number] => 05162341 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Use of sigma receptor antagonists for treatment of amphetamine abuse' [patent_app_type] => 1 [patent_app_number] => 7/659443 [patent_app_country] => US [patent_app_date] => 1991-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5131 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 545 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162341.pdf [firstpage_image] =>[orig_patent_app_number] => 659443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2947159 [patent_doc_number] => 05180729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-19 [patent_title] => 'Use of sigma receptor antagonists for treatment of cocaine abuse' [patent_app_type] => 1 [patent_app_number] => 7/659444 [patent_app_country] => US [patent_app_date] => 1991-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5934 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/180/05180729.pdf [firstpage_image] =>[orig_patent_app_number] => 659444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2813044 [patent_doc_number] => 05086050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-02-04 [patent_title] => 'Method of treating inflammatory disorders and psoriasis with salts of azelastine' [patent_app_type] => 1 [patent_app_number] => 7/652986 [patent_app_country] => US [patent_app_date] => 1991-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4315 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/086/05086050.pdf [firstpage_image] =>[orig_patent_app_number] => 652986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2853018 [patent_doc_number] => 05134129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-28 [patent_title] => 'Methods employing unique mixtures of polar and neutral lipids for surfactant replacement therapy' [patent_app_type] => 1 [patent_app_number] => 7/636672 [patent_app_country] => US [patent_app_date] => 1991-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 20095 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/134/05134129.pdf [firstpage_image] =>[orig_patent_app_number] => 636672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2805662 [patent_doc_number] => 05114974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-19 [patent_title] => 'Treatment of atherosclerosis with MgNa.sub.2 EDTA' [patent_app_type] => 1 [patent_app_number] => 7/647965 [patent_app_country] => US [patent_app_date] => 1991-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3991 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/114/05114974.pdf [firstpage_image] =>[orig_patent_app_number] => 647965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2868145 [patent_doc_number] => 05162366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Antioxidant composition in vivo comprising enol form .delta.-lactone of diketogulonic acid' [patent_app_type] => 1 [patent_app_number] => 7/645487 [patent_app_country] => US [patent_app_date] => 1991-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 4176 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162366.pdf [firstpage_image] =>[orig_patent_app_number] => 645487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2955278 [patent_doc_number] => 05198230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-30 [patent_title] => 'Composition called DTS (deities) for the treatment of addictive disease' [patent_app_type] => 1 [patent_app_number] => 7/638780 [patent_app_country] => US [patent_app_date] => 1991-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3470 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/198/05198230.pdf [firstpage_image] =>[orig_patent_app_number] => 638780 [rel_patent_id] =>[rel_patent_doc_number] =>)